1-2 of 2
Francesco Ricciuti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Clinical Trials & Observations
Sergio Amadori, Stefan Suciu, Ulrich Jehn, Roberto Stasi, Xavier Thomas, Jean-Pierre Marie, Petra Muus, Francois Lefrère, Zwi Berneman, George Fillet, Claudio Denzlinger, Roel Willemze, Pietro Leoni, Giuseppe Leone, Marco Casini, Francesco Ricciuti, Marco Vignetti, Filip Beeldens, Franco Mandelli, Theo De Witte, for the EORTC/GIMEMA Leukemia Groups
Journal: Blood
Blood (2005) 106 (1): 27–34.
https://doi.org/10.1182/blood-2004-09-3728
Published: 2005
Journal Articles

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up

Clinical Trials & Observations
Giuseppe Avvisati, Maria Concetta Petti, Francesco Lo-Coco, Maria Luce Vegna, Sergio Amadori, Michele Baccarani, Nicola Cantore, Eros Di Bona, Felicetto Ferrara, Giuseppe Fioritoni, Eugenio Gallo, Rosangela Invernizzi, Mario Lazzarino, Vincenzo Liso, Guglielmo Mariani, Francesco Ricciuti, Carmine Selleri, Simona Sica, Dino Veneri, Franco Mandelli
Journal: Blood
Blood (2002) 100 (9): 3141–3146.
https://doi.org/10.1182/blood-2002-02-0352
Published: 2002